INDICAID COVID-19/FLU A&B Rapid Antigen Test Authorized for Use by the Ministry of Health of New Zealand

PHASE Scientific announces that its INDICAID™ COVID-19/Flu A&B Rapid Antigen Test has received approval from the New Zealand Medicines and Medical Devices Safety Authority of the Ministry of Health New Zealand. The authorization allows our Test to be used in the country for identification of COVID-19/Flu A&B cases.

Flu season began earlier than usual this year In New Zealand, with flu-positive hospitalizations exceeding the seasonal baseline in April for the first time. Since the symptoms of flu infections are similar to those of COVID-19 and other respiratory illnesses, knowing which virus is responsible for these symptoms is crucial for timely and more accurate treatment.

INDICAID™ COVID-19/Flu A&B Rapid Antigen Test is a 3-in-1 test, the perfect right tool to detect and differentiate among SARS-CoV-2, Influenza A&B viruses at once.

Learn more about INDICAID™ COVID-19/Flu A&B Rapid Antigen Test at https://phasescientific.com/products-and-services/indicaid/indicaid-covid-flu-rat.